We’ve moved

The Rosalind and Morris Goodman Cancer Institute can now be found at www.goodmancancer.ca

Visit the new site

 

Home / Articles

Rosalind and Morris Goodman Cancer Institute Trainees Awarded 1.9M$ in Provincial and National Research Funding.

12 Jul 2022

This year, the GCI master's students, doctoral students and post-doctoral fellows excelled in provincial and national funding opportunities. Together, 29 students were awarded 1.9M$ by the Fonds de...

GCI Paper Highlight - MOB3A Bypasses BRAF and RAS Oncogene-Induced Senescence by Engaging the Hippo Pathway

22 Jun 2022

David Dankort’s lab’s latest paper in @MCR_AACR identifies the Hippo pathway inhibitor MOB3A as a novel suppressor of RAS and BRAF oncogene-induced senescence. Re-engagement of the Hippo pathway by...

GCI Researchers Claim Awards and Honours Nationally and Internationally

20 Jun 2022

Michel Tremblay, Ph.D., was awarded an honoris causa doctorate from Bordeaux University (France)....

Alumni Webcast: How mRNA Vaccines Might Change the Course of Medical History

20 Jun 2022

Made by McGill hosts a webcast series in which they discuss current societal topics with a panel of McGill experts. These hour-long conversations enrich the listeners’ understanding of an important...

Santé Gala: The Road to RNA Therapies.

14 Jun 2022

On June 15, the Santé Gala will be hosted by the Rosalind and Morris Goodman Cancer Institute (GCI). The gala will celebrate the legacy and future of mRNA biology research at the GCI. Amidst the...

Pages

Back to top